semaglutide and cardiovascular outcomes in obesity without diabetes journal club Population‐level impact of semaglutide Evaluating the Cardiovascular Benefits of

For every 1% reduction in weight , there was a 3.1% lower risk of discontinuation for those with type 2 diabetes and 3.3% for those without

Unlike oral supplements, an injection delivers vitamin B12 directly into the body without relying on digestive absorption which can be reduced by age, certain medications such as proton pump inhibitors or metformin, or gastrointestinal conditions

This review paper will critically examine the compelling arguments in favor of nanoparticles as an innovative and cutting-edge method for managing asthma

It was developed in Russia and is studied mainly as an anxiolytic (anti-anxiety) and anti-asthenic agent

Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, et al